Search Results 1131-1140 of 16419 for monoclonal antibody

1. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

   ... monoclonal antibodies, including therapeutic antibodies. Patients with the following infectious diseases are excluded: known HIV;; active Hepatitis B ...

2. A Study to Evaluate Larotrectinib to Treat Patients with Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

   Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to grade ≤ 1.

3. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

   Known severe hypersensitivity reactions to monoclonal antibodies (Grade ≥ 3 NCI-CTC V4.03 or V5.0 for phase II part 2), any history of anaphylaxis, or ...

4. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

   Have received any monoclonal antibody therapy directed at treatment of the patient's malignancy within 2 weeks prior to anticipated first dose. Have ...

5. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... monoclonal antibody (MetMAb); prior antibody therapy such as bevacizumab or cetuximab is allowed with a washout period depending on dosing interval and ...

6. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   Participation eligibility · Subjects who are hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative will need to have a negative ...

7. Myeloma Referral Study (Race, Ethnicity, and Familial Etiologic Relationship, Risk Association, and Linkage Study) - Mayo Clinic

   About this study. The goal of the present study is to answer the question of whether there are clinically relevant subtypes of monoclonal gammopathy of ...

8. Mayo Clinic Biobank - Autoimmune Disorders

   ... antibodies can differentiate inflammatory bowel disease from healthy ... Camilleri, M.D., is working to develop a new test to detect a specific antibody ...

9. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   ... antibody positive but HCV RNA negative due to documented, curative prior antiviral treatment or natural resolution is eligible) * Positive test for ...

10. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

    Anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 negative; and; An anthracycline containing chemotherapy regimen. Intent to ...